Lascoña, Niviana Colene .

HRN: 27-15-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
AMPICILLIN 250MG (VIAL)
05/29/2025
06/04/2025
IV
200mg
Q12
PSNB
Waiting Final Action 
05/29/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/29/2025
06/04/2025
IV
40mg
OD
PSNB
Waiting Final Action 
01/09/2026
CEFUROXIME 750MG (VIAL)
01/09/2026
01/16/2026
IV
315 MG
Q8HRS
PCAP C
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: